Synopsys
SNPS
502.67
-2.50
-0.49%
Synopsys
US · SNPS
#304 by market cap
Listed 1970
502.67
-2.50
-0.49%
Live - 5344 symbols - heartbeat 63s ago
· 2026-10-08 07:00
Pre-market
498.25
-0.88%
After-hours
503.00
+0.07%
Overnight
499.99
-0.53%
- Market cap
- 96.33B
- P/E (TTM)i
- 87.88
- P/Bi
- 3.09
- EPSi
- 8.04
- Div yieldi
- 0.00%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on SNPS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.47, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.12% YoY
Margins
- Gross margin
- 76.98%
- Operating margin
- 12.97%
- Net margin
- 18.89%
Key ratios & quality
- Enterprise valuei
- 106.98B
- PEG ratioi
- 8.29
- Altman Z-Scorei
- 3.47
PEG uses trailing P/E against the 3-year net income growth rate (10.60%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.12B | 3.36B | 3.69B | 4.20B | 4.62B | 5.32B | 6.13B | 7.05B |
| Gross profit | 2.39B | 2.61B | 2.89B | 3.34B | 3.72B | 4.29B | 4.88B | 5.43B |
| Selling & admin expenses | 885.54M | 862.11M | 916.54M | 1.04B | 956.28M | 1.10B | 1.43B | 1.84B |
| Research & development | 1.08B | 1.14B | 1.28B | 1.50B | 1.59B | 1.85B | 2.08B | 2.48B |
| Operating profit | 373.17M | 567.42M | 656.20M | 768.20M | 1.16B | 1.33B | 1.36B | 914.93M |
| Pretax profit | 363.54M | 545.51M | 638.16M | 805.51M | 1.10B | 1.31B | 1.51B | 1.39B |
| Tax | -68.98M | 13.14M | -25.29M | 49.16M | 139.39M | 90.19M | 99.72M | 55.99M |
| Net profit | 432.52M | 532.37M | 663.45M | 756.36M | 978.44M | 1.22B | 2.24B | 1.33B |
| Basic EPS | 3 | 4 | 4 | 5 | 6 | 8 | 15 | 8 |
| Diluted EPS | 2.82 | 3.45 | 4.27 | 4.81 | 6.29 | 7.92 | 14.51 | 8.04 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.60B | 1.74B | 2.25B | 2.41B | 2.28B | 2.48B |
| Gross profit | 1.29B | 1.36B | 1.60B | 1.77B | 1.65B | 1.80B |
| Selling & admin expenses | 351.52M | 540.03M | 576.01M | 579.11M | 554.42M | 562.87M |
| Research & development | 553.98M | 625.30M | 746.84M | 714.99M | 700.12M | 719.74M |
| Operating profit | 376.43M | 165.27M | 121.39M | 321.33M | 236.32M | 359.66M |
| Pretax profit | 396.19M | 189.31M | 516.52M | 79.05M | 19.28M | 683.92M |
| Tax | 47.18M | -52.97M | 68.07M | 14.34M | 2.41M | 138.22M |
| Net profit | 345.11M | 242.28M | 448.45M | 65.20M | 16.87M | 545.71M |
| Basic EPS | 2 | 2 | 2 | 0 | 0 | 3 |
| Diluted EPS | 2.21 | 1.50 | 2.39 | 0.34 | 0.09 | 2.84 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.54B | 1.74B | 2.55B | 2.81B | 3.01B | 3.43B | 6.47B | 6.01B |
| Cash & ST investments | 723.12M | 728.60M | 1.24B | 1.58B | 1.57B | 1.59B | 4.05B | 2.96B |
| Inventory | 122.41M | 141.52M | 192.33M | 229.02M | 211.93M | 325.59M | 361.85M | 365.19M |
| Total assets | 6.15B | 6.41B | 8.03B | 8.75B | 9.42B | 10.33B | 13.07B | 48.22B |
| Total current liabilities | 2.10B | 1.75B | 2.14B | 2.41B | 2.77B | 2.99B | 2.65B | 3.72B |
| Short-term debt | 343.77M | 17.61M | 100.26M | 154.67M | 54.27M | 79.83M | 94.79M | 150.32M |
| Long-term debt | 125.54M | 120.09M | 100.82M | 25.09M | 20.82M | 18.08M | 15.60M | 13.46B |
| Total liabilities | 2,660,959,000.00 | 2,316,284,000.00 | 3,117,695,000.00 | 3,453,317,000.00 | 3,858,897,000.00 | 4,148,830,000.00 | 4,050,355,000.00 | 19,897,446,000.00 |
| Total equity | 3.49B | 4.09B | 4.91B | 5.30B | 5.56B | 6.18B | 9.02B | 28.33B |
| Retained earnings | 2.54B | 3.16B | 3.80B | 4.55B | 5.53B | 6.74B | 8.98B | 10.32B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 16.88B | 5.60B | 6.01B | 5.37B | 5.44B | 6.64B |
| Cash & ST investments | 14.26B | 2.59B | 2.96B | 2.20B | 2.48B | 3.61B |
| Inventory | 395.34M | 382.06M | 365.19M | 393.22M | 441.84M | 479.13M |
| Total assets | 23.76B | 48.23B | 48.22B | 47.24B | 46.89B | 47.73B |
| Total current liabilities | 2.41B | 3.44B | 3.72B | 3.94B | 3.79B | 4.97B |
| Short-term debt | 127.13M | 149.57M | 150.32M | 155.22M | 157.64M | 1.16B |
| Long-term debt | 10.03B | 14.32B | 13.46B | 10.02B | 10.01B | 9.02B |
| Total liabilities | 13,840,912,000.00 | 20,616,070,000.00 | 19,897,446,000.00 | 16,689,930,000.00 | 16,411,962,000.00 | 16,574,884,000.00 |
| Total equity | 9.92B | 27.61B | 28.33B | 30.55B | 30.48B | 31.15B |
| Retained earnings | 9.62B | 9.87B | 10.32B | 10.38B | 10.40B | 10.94B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 424.40M | 800.51M | 991.31M | 1.49B | 1.74B | 1.70B | 1.41B | 1.52B |
| Depreciation & amortization | 209.21M | 201.68M | 209.99M | 203.68M | 228.41M | 247.12M | 295.07M | 660.43M |
| Free cash flow | 322.47M | 598.13M | 832.55M | 1.40B | 1.60B | 1.51B | 1.27B | 1.35B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -276.17M | -172.82M | -44.68M | -542.36M | -862.04M | -907.74M | 232.21M | 228.42M |
| Ending cash balance | 725.00M | 730.53M | 1.24B | 1.44B | 1.42B | 1.44B | 3.90B | 2.89B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 275.37M | 670.96M | 639.74M | 856.83M | 628.93M | 812.84M |
| Depreciation & amortization | 48.90M | 114.47M | 449.12M | 450.69M | 456.49M | 454.84M |
| Free cash flow | 219.78M | 632.36M | 605.19M | 821.51M | 574.74M | 746.27M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 103.89M | 19.79M | 90.32M | 2.01B | -159.11M | -29.05M |
| Ending cash balance | 14.12B | 2.53B | 2.89B | 2.13B | 2.42B | 3.61B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.81 | 14.08 | 14.78 | 14.85 | 18.21 | 21.09 | 29.90 | 7.14 |
| ROA %i | 7.49 | 8.48 | 9.20 | 9.03 | 10.84 | 12.45 | 19.34 | 4.35 |
| ROIC %i | 11.85 | 12.49 | 13.27 | 11.99 | 17.12 | 18.11 | 27.06 | 5.72 |
| 5-year avg ROE %i | 8.33 | 9.37 | 10.86 | 12.15 | 14.95 | 16.60 | 19.77 | 18.24 |
| EBIT margin %i | 12.15 | 16.58 | 17.46 | 19.24 | 21.99 | 22.30 | 25.28 | 26.08 |
| FCF / sales %i | 10.33 | 17.80 | 22.59 | 33.23 | 31.48 | 25.87 | 20.95 | 19.13 |
| Current ratioi | 0.73 | 0.99 | 1.19 | 1.16 | 1.09 | 1.15 | 2.44 | 1.62 |
| Quick ratioi | 0.64 | 0.75 | 0.96 | 0.89 | 0.85 | 0.82 | 1.88 | 1.20 |
| Debt / assetsi | 7.64 | 2.15 | 8.26 | 7.62 | 6.97 | 6.56 | 5.24 | 29.64 |
| LT debt / equityi | 3.61 | 2.94 | 11.48 | 9.67 | 10.92 | 9.72 | 6.56 | 49.93 |
| Interest coveragei | 24.29 | 47.79 | 125.16 | 240.38 | 657.96 | 1,106.08 | 44.06 | 4.12 |
| Revenue CAGR (3Y) %i | 11.65 | 11.53 | 10.59 | 10.44 | 11.16 | 13.00 | 13.38 | 15.19 |
| Net income CAGR (3Y) %i | 24.17 | 25.89 | 69.44 | 20.54 | 22.75 | 22.79 | 44.03 | 10.60 |
| FCF CAGR (3Y) %i | -7.28 | 5.07 | 14.21 | 63.01 | 38.81 | 21.99 | -3.19 | -5.52 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 25.35 | 11.31 | 7.14 | 5.53 | 3.83 | 3.66 |
| ROA %i | 12.44 | 6.67 | 4.35 | 3.65 | 2.19 | 2.24 |
| ROIC %i | 14.96 | 7.75 | 5.72 | 5.52 | 3.91 | 3.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 24.66 | 22.78 | 26.08 | 22.22 | 16.61 | 20.42 |
| FCF / sales %i | 17.45 | 20.24 | 19.13 | 28.46 | 30.35 | 29.18 |
| Current ratioi | 7.02 | 1.62 | 1.62 | 1.36 | 1.43 | 1.34 |
| Quick ratioi | 6.34 | 1.16 | 1.20 | 0.98 | 0.99 | 0.99 |
| Debt / assetsi | 45.22 | 31.39 | 29.64 | 23.01 | 23.12 | 22.72 |
| LT debt / equityi | 107.05 | 54.29 | 49.93 | 35.07 | 35.06 | 31.08 |
| Interest coveragei | 11.64 | 5.50 | 4.12 | 2.97 | 2.26 | 3.08 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Design Automation is the largest reported line at 80.87% of revenue, across 2 reported segments.
- The next-largest line, Design Intellectual Property (IP), is a distant second at 19.13% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Design Automation80.87%
Design Intellectual Property (IP)19.13%
Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.